Institute for Applied Biomedicine is developing drugs to treat immune system diseases including AIDS. The Institute is a not-for-profit biotechnology firm committed to making our drugs accessible to all.
We are in pre-clinical testing for a new AIDS drug, which
is designed to keep the immune system of an HIV-positive
person healthy. Initial test results have been clearly
We are developing treatments for autoimmune diseases such as
rheumatoid arthritis and lupus. We have filed for patent
protection on our broad, immune-modifying technology.
- Overview - an overview of
our organization and research, with links to more
- Product Pipeline - the
Institute's drugs for immune system diseases other than AIDS; drug
- Our AIDS Drug: Immudel™-gp120 -
the Institute's experimental AIDS drug; results of pilot tests;
drug development plans; the Institute's Medical
and references; expert
review; general information about AIDS; AIDS-related annotated
links. Information on both non-technical and technical levels.
- Support Our Research - on-line
and off-line donations, volunteering, and other opportunities
to support our research and drug development; confidential
Please Contact Us via email, phone,
fax, or mail with questions, comments, or
This web site designed and maintained by
Institute for Applied Biomedicine. All Rights Reserved. Legal Notices.